Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Taipei Exchange - Delayed Quote TWD

Johnson Chemical Pharmaceutical Works Co., Ltd. (4747.TWO)

Compare
71.50
+1.20
+(1.71%)
At close: April 2 at 1:30:15 PM GMT+8
Loading Chart for 4747.TWO
  • Previous Close 70.30
  • Open 70.30
  • Bid --
  • Ask --
  • Day's Range 70.10 - 72.80
  • 52 Week Range 61.20 - 88.30
  • Volume 176,406
  • Avg. Volume 164,333
  • Market Cap (intraday) 3.212B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 38.44
  • EPS (TTM) 1.86
  • Earnings Date --
  • Forward Dividend & Yield 1.50 (2.10%)
  • Ex-Dividend Date Jun 21, 2024
  • 1y Target Est --

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was founded in 1959 and is based in New Taipei City, Taiwan.

www.jcpjohnson.com.tw

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 4747.TWO

View More

Performance Overview: 4747.TWO

Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

4747.TWO
0.00%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
7.54%

1-Year Return

4747.TWO
5.62%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
4.06%

3-Year Return

4747.TWO
156.43%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
20.84%

5-Year Return

4747.TWO
92.25%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
120.40%

Compare To: 4747.TWO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4747.TWO

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    3.21B

  • Enterprise Value

    2.29B

  • Trailing P/E

    38.44

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.29

  • Price/Book (mrq)

    1.89

  • Enterprise Value/Revenue

    3.75

  • Enterprise Value/EBITDA

    17.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.76%

  • Return on Assets (ttm)

    3.10%

  • Return on Equity (ttm)

    4.98%

  • Revenue (ttm)

    611.41M

  • Net Income Avi to Common (ttm)

    84.12M

  • Diluted EPS (ttm)

    1.86

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.07B

  • Total Debt/Equity (mrq)

    8.82%

  • Levered Free Cash Flow (ttm)

    22.48M

Research Analysis: 4747.TWO

View More

Company Insights: 4747.TWO

Research Reports: 4747.TWO

View More

People Also Watch